AI assistant
Sending…
Q/C TECHNOLOGIES, INC. — Director's Dealing 2019
Sep 5, 2019
35313_dirs_2019-09-04_419a75b6-7a6f-4d47-9a93-d5b129b807cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2019-08-30
Reporting Person: Yeaton Howard (CEO, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-30 | Common Stock | A | 3750 | $0.43 | Acquired | 41250 | Direct |
More from Q/C TECHNOLOGIES, INC.
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 29
Annual Report
2026
Apr 15
Regulatory Filings
2026
Feb 11
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Regulatory Filings
2026
Jan 23
Regulatory Filings
2025
Dec 9
Regulatory Filings
2025
Dec 1
Regulatory Filings
2025
Dec 1